TiO2-nanowired delivery of DL-3-n-butylphthalide (DL-NBP) attenuates blood-brain barrier disruption, brain edema formation, and neuronal damages following concussive head injury
dc.creator | Feng L. | |
dc.creator | Sharma A. | |
dc.creator | Niu F. | |
dc.creator | Huang Y. | |
dc.creator | Lafuente J.V. | |
dc.creator | Muresanu D.F. | |
dc.creator | Ozkizilcik A. | |
dc.creator | Tian Z.R. | |
dc.creator | Sharma H.S. | |
dc.date.accessioned | 2020-09-02T22:17:25Z | |
dc.date.accessioned | 2022-11-08T20:25:22Z | |
dc.date.available | 2020-09-02T22:17:25Z | |
dc.date.available | 2022-11-08T20:25:22Z | |
dc.date.created | 2020-09-02T22:17:25Z | |
dc.date.issued | 2018 | |
dc.identifier | 55, 1, 350-358 | |
dc.identifier | 08937648 | |
dc.identifier | https://hdl.handle.net/20.500.12728/4434 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145632 | |
dc.language | en | |
dc.publisher | Humana Press Inc. | |
dc.subject | Blood-brain barrier | |
dc.subject | Brain edema | |
dc.subject | Concussive head injury (CHI) | |
dc.subject | DL-3-n-butylphthalide (DL-NBP) | |
dc.subject | Neuronal injury | |
dc.subject | Neuroprotection | |
dc.subject | TiO2 nanodelivery | |
dc.subject | butylphthalide | |
dc.subject | Evans blue | |
dc.subject | iodine 131 | |
dc.subject | nanowire | |
dc.subject | titanium dioxide | |
dc.subject | 3-n-butylphthalide | |
dc.subject | benzofuran derivative | |
dc.subject | nanowire | |
dc.subject | neuroprotective agent | |
dc.subject | titanium | |
dc.subject | titanium dioxide | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | blood brain barrier | |
dc.subject | brain damage | |
dc.subject | brain edema | |
dc.subject | brain tissue | |
dc.subject | concussive head injury | |
dc.subject | concussive head injury | |
dc.subject | controlled study | |
dc.subject | drug delivery system | |
dc.subject | drug efficacy | |
dc.subject | head injury | |
dc.subject | histopathology | |
dc.subject | male | |
dc.subject | nervous system injury | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | parietal bone | |
dc.subject | rat | |
dc.subject | survival | |
dc.subject | animal | |
dc.subject | blood brain barrier | |
dc.subject | brain concussion | |
dc.subject | brain edema | |
dc.subject | complication | |
dc.subject | drug delivery system | |
dc.subject | drug effect | |
dc.subject | nerve cell | |
dc.subject | pathology | |
dc.subject | procedures | |
dc.subject | Wistar rat | |
dc.subject | Animals | |
dc.subject | Benzofurans | |
dc.subject | Blood-Brain Barrier | |
dc.subject | Brain Concussion | |
dc.subject | Brain Edema | |
dc.subject | Drug Delivery Systems | |
dc.subject | Male | |
dc.subject | Nanowires | |
dc.subject | Neurons | |
dc.subject | Neuroprotective Agents | |
dc.subject | Rats | |
dc.subject | Rats, Wistar | |
dc.subject | Titanium | |
dc.title | TiO2-nanowired delivery of DL-3-n-butylphthalide (DL-NBP) attenuates blood-brain barrier disruption, brain edema formation, and neuronal damages following concussive head injury | |
dc.type | Article |